These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 224643)

  • 1. [Hypobetalipoproteinemic effect of trans-2,10-dichloro-6-ethoxycarbonyl-12-methyldibenzo[d,g] [1,3]dioxocin (EGYT-1932, Crismel)].
    Maderspach A; Orbán E
    Acta Pharm Hung; 1979 Jul; 49(4):182-6. PubMed ID: 224643
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid decreasing effect of trans-2,10-dichloro-6-ethoxycarbonyl-12-methyldibenzo[d,g] [1,3]dioxocin (EGYT-1932, Crismel)].
    Maderspach A; Orbán E; Borsy J; Fischer J
    Acta Pharm Hung; 1979 Jul; 49(4):174-81. PubMed ID: 474140
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypolipidemic action of beta-D-glycoside beta-sitosterol in the rat].
    Mironova VN; Kalashnikova LA
    Farmakol Toksikol; 1982; 45(6):45-7. PubMed ID: 7151999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypobetalipoproteinemic agents. 2. Compounds related to 4-(1-adamantyloxy)aniline.
    Lednicer D; Heyd WE; Emmert DE; TenBrink RE; Schurr PE; Day CE
    J Med Chem; 1979 Jan; 22(1):69-77. PubMed ID: 218007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
    Superko HR; McGovern ME; Raul E; Garrett B
    Am J Cardiol; 2004 Sep; 94(5):588-94. PubMed ID: 15342288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
    Geiss HC; Schwandt P; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid lowering: myth or therapeutic necessity?].
    Dtsch Med Wochenschr; 1998 Oct; 123(40 Suppl):2-8. PubMed ID: 9793486
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of high-density lipoproteins on the permeability of the rabbit aorta for low-density lipoproteins].
    Klimov AN; Popov AV; Nagornev VA; Pleskov VM
    Vopr Med Khim; 1984; 30(6):9-12. PubMed ID: 6528542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Soya protein-lipid complex as a corrective agent of lipid metabolism and functional state in moderate hypercholesteremia].
    Tsyganova TB; Klassina SIa; Konotop NS
    Vopr Pitan; 2001; 70(1):25-8. PubMed ID: 11338342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of linseed oil on fatty acid composition of low- and very low density lipoproteins, cholesterol and its fractions in the blood serum of albino rats].
    Kaminskas A; Mikalauskaĭte DA; Levachev MM; Lupinovich VL
    Vopr Pitan; 1991; (5):48-51. PubMed ID: 1796574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethyl 2-([5,6-dihydro-7-(1H-imidazol-1-yl)-2-naphthalenyl]oxy)- 2-methylpropanoate as a new potent oxyisobutyrate hypolipidaemic with unusual features.
    Cozzi P; Branzoli U; Carganico G; Chiari A; Lovisolo PP; Severino D
    Farmaco Sci; 1987 Mar; 42(3):205-18. PubMed ID: 3653387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipoprotein regulatory effect of molsodomine in rats].
    Granzer E; Ostrowski J
    Arzneimittelforschung; 1984; 34(2):191-3. PubMed ID: 6547045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surface properties and size of very low and low density lipoproteins in human plasma in normal states and in hypercholesterolemia].
    Voziian PA; Kholodova IuD; Smirnova IP; Chobot'ko GM
    Vopr Med Khim; 1988; 34(1):101-5. PubMed ID: 3369119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of protamine on blood lipoproteins in the early period of hypercholesterolemia in rabbits].
    Bozhko GKh; Boĭkov TP; Kostiukovskaia LS; Voloshin PV
    Biull Eksp Biol Med; 1990 Jul; 110(7):40-2. PubMed ID: 2224096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercholesterolemia in ExHC rats and lipid-lowering drug: a screening method for new hypocholesterolemic agents.
    Kitazaki T; Tsuda M; Matsumura H; Ohtagaki T; Imai Y
    Artery; 1981; 9(6):414-24. PubMed ID: 6802106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of fibrates.
    Shepherd J
    Postgrad Med J; 1993; 69 Suppl 1():S34-41. PubMed ID: 8497455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bezafibrate and gemfibrozil on serum lipoproteins in primary hypercholesterolemia.
    Weisweiler P
    Arzneimittelforschung; 1988 Jul; 38(7):925-7. PubMed ID: 3207437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo catabolism of lipid and protein moieties of blood very low and low density lipoproteins in rabbits].
    Klimov AI; Andreeva LI; Popov AV
    Vopr Med Khim; 1982; 28(1):131-5. PubMed ID: 7064379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.